Analysts/Institutional Investor Meet/Con. Call Updates

Date: October 14, 2026 The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited (NSE) BSE Limited (BSE) Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C/1, G-Block Dalal Street Bandra-Kurla Complex Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code:544282 Symbol: SAGILITY Dear Sir/Ma’am, Subject: Intimation of investors call pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, investor/analyst webinar for discussing the unaudited financial results of the Company for quarter and half year ended September 30, 2026, will be held on October 22, 2026, at 7:30 PM. The details of the call are provided as an annexure to this letter. The details are also being made available on the Company’s website https://sagility.com/ This is for your kind information and record. Thanking You, For Sagility Limited Satishkumar Sakharayapattana Seetharamaiah Company Secretary & Compliance Officer Membership No: A16008 Encl:a/a Sagility Limited (Formerly Sagility India Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru – 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com Sagility Limited. Q2 FY27 Earnings Webinar Thursday, October 22, 2026, at 7:30 PM IST Bengaluru, October 14, 2026 — Sagility Limited (SAGILITY), a technology-enabled, pure-play healthcare focused solutions and services provider, will host its earnings webinar for analysts and investors on Thursday, October 22, 2026, at 7:30 PM IST. The call will commence with a discussion on the business, followed by operational and financial highlights for the quarter ended September 30, 2026. There is an interactive Question & Answer session planned after the presentation. The Company will be represented by • Mr. Ramesh Gopalan – Managing Director and Group CEO • Mr. Srinivas Rathnam Mattapalli – Group Chief Financial Officer Dial-in details are as follows: Timing 7:30 PM IST on Thursday, October 22, 2026. https://zoom.us/webinar/register/WN_do1XhaEOR92q- Pre-registration Link QjwmdMKAQ Webinar ID 982 6566 5207 Passcode 355720 • Platform: Zoom. Please download the latest app for your device: Download Link. • Pre-Registration: Mandatory. Register up to 3 hours before the call using the provided link. • Q&A Session: After management's commentary, participants may join the queue by clicking the “Raise Hand” icon during the commentary. When announced, unmute yourself using the “Unmute Me” button to ask your question. About Sagility Limited. Sagility is a technology-enabled, healthcare-focused solutions and services provider that supports U.S.-based payers, providers, and their partners in delivering best-in-class operations, enhancing member and provider experiences, and improving the quality of care, all while ensuring cost-effective financial and clinical outcomes. With over two decades of experience, Sagility’s dedicated experts address complex healthcare challenges through deep domain expertise and innovative thinking. The company serves five of the top ten health insurance companies in the U.S., utilizing its advanced technology, processes, and solutions to ensure efficient operations and minimize additional administrative costs. The Company delivers these services through its skilled talent pool across five global service delivery centers located in India, the Philippines, the U.S., Jamaica, and Colombia. For more information, please visit www.sagility.com OR contact: Mr. Abhishek Kayan Siddharth Rangnekar Sagility Limited CDR India Email: investorservices@sagility.com Email: siddharth@cdr-india.com Safe Harbor: Certain statements made in this call concerning our future growth prospects may be interpreted as forward-looking statements, which involve a number of risks and uncertainties that could cause the actual results to differ materially from those in such forward-looking statements. Investors are requested to use their discretion in relying on them. We do not undertake to update any forward-looking statements that may be made from time to time.